Spectral and Microbial Studies of some Newly Synthesized Schiff Base Derivatives of 2-(1H-benzo[d]oxazole-2-ylthio)-N-(4-acetylphenyl)acetamide

• Autorzy: Maru J.J. , Patel G. R. , Yadav R.

Identyfikatory

DOI

10.18052/www.scipress.com/ILCPA.44.57

• Języki publikacji: EN

Abstrakty

EN

The author has synthesized novel biological active compounds by condensation of N-(4-Acetyl-phenyl)-2-(benzooxazol-2-ylsulfanyl)-acetamide with defferent substituted of acid hydrazide in the presence of catalytic amount of acetic acid. A series of benzoxazole having azomethine group were confirmed by various spectroscopic techniques. The new compounds were examined for antibacterial effects again different strain of bacteria and antifungal were high to lowest Minimum Inhibition Concentration (MIC) values.

Słowa kluczowe

EN

Benzoxazole; Acid hydrazied; Azomethine

• Wydawca: Przedsiębiorstwo Wydawnictw Naukowych "DARWIN"
• Czasopismo: International Letters of Chemistry, Physics and Astronomy
• Rocznik: 2015
• Tom: Vol. 44
• Strony: 57--65
• Opis fizyczny: Bibliogr. 16 poz., tab., wz.

Twórcy

autor

Maru J.J.

• Department of Chemistry, Sheth M. N. Science College, NGES campus, Patan - 384265, India

autor

Patel G. R.

• Department of Chemistry, Sheth M. N. Science College, NGES campus, Patan - 384265, India

autor

Yadav R.

• Department of Chemistry, Sheth M. N. Science College, NGES campus, Patan - 384265, India

Bibliografia

• [1] T. Panneer Selvam, P. P. Radhika, S. Janagaraj, A. Siva Kumar, Research In biotechnology 2 (2011) 50-57.
• [2] Pedrazzini S, De Angelis M, Muciaccia WZ, Sacchi C, Forgione A, Arzneimittel-Forschung 38 (8): 1170–5. PMID 3196413
• [3] Samia M. Rida, Fawzia A. Ashour, Soad A.M. El-Hawash, Mona M. ElSemary, Mona H. Badr, Manal A. Shalaby, Eur J Med Chem 40 (2005) 949-959.
• [4] Jarmila Vinsova, Vaclav Horak, Vladimir Buchta and Jarmila Kaustova, Molecules 10 (2005) 783-793.
• [5] Meric Koksal, Nesrin Gokhan, Esra Kupeli, Erdem Yesilada, and Hakki Erdogan, Arch Pharm Res. 30 (2007) 419-424.
• [6] Mimnaugh, E.G.; Xu, W.; Vos, M. Mol. Cancer Ther. 3 (2004) 551–566.
• [7] Yadav, R; Sirvastava, SD and Sirvastava, SK (2005), Indian J. Chem. 44 (2005) 1262-1266.
• [8] Ramón, G; Domenech, B; Ana, C; Gregori, C and Calabuig, C, Internet Electron. J. Mol. Des., BioChem Press,1 (2002) 339-350.
• [9] R. V. Satyendra, K. A. Vishnumurthy, H. M. Vagdevi, K. P. Rajesh, H. Manjunatha,and A. Shruthi, European Journal of Medicinal Chemistry 46 (2011) 3078–3084.
• [10] Paramashivappa R, Phanikumar P, Subbarao P, Srinivasarao A, Bioorg Med Chem Lett. 13, 2003, 657-660.
• [11] Grocer, H., Kus, C., Boykin, D.W., Yildiz, S., Altanlar, N., Bioorg. Med. Chem.10 (2002) 2589-2596.
• [12] Nicholson R. M, Murphy J. R, Dearden J. R, Journal of Pharmacy and Pharmacology 34 (1982) 106-111.
• [13] Fang, B., Zhou, C.H., Rao, X.C., Eur. J. Med. Chem. 45 (2010) 4388-4398.
• [14] E. F. Magomedova, V. V. Pinyaskin, A. Sh. Aminova, Pharma. Chem. J. 41 (2007) 474-475.
• [15] Kalpesh Parikh, Deepkumar Joshi, Med Chem Res. 22 (2013) 3688-3697.
• [16] P.C. Hannan, Vet. Res. 31 (2000) 373-395.